Mayo Clinic's blood disorder researchers are actively studying new ways of treating chronic myelogenous leukemia.

Blood cell and bone marrow cancer research is conducted by the Hematologic Malignancies Program in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.


See a list of publications on chronic myelogenous leukemia by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

May 26, 2016
  1. Chronic myelogenous leukemia. Fort Washington, Pa.: National Comprehensive Cancer Network. Accessed Dec. 22, 2015.
  2. Chronic myelogenous leukemia treatment (PDQ). National Cancer Institute. Accessed Jan. 3, 2016.
  3. Lichtman MA, et al. Chronic myelogenous leukemia and related disorders. In: Williams Hematology. 8th ed. New York, N.Y.: The McGraw-Hill Companies; 2010. Accessed Jan. 3, 2016.
  4. Niederhuber JE, et al. eds. Chronic myeloid leukemia. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. Accessed Dec. 22, 2015.
  5. Integrative medicine and complementary and alternative therapies as part of blood cancer care. The Leukemia & Lymphoma Society. Accessed Jan. 3, 2016.
  6. When cancer doesn't go away. American Cancer Society. Accessed Jan. 3, 2016.
  7. About us. Mayo Medical Laboratories. Accessed Jan. 3, 2016.
  8. AskMayoExpert. Chronic myelogenous leukemia. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  9. Van Etten RA. Clinical manifestations and diagnosis of chronic myeloid leukemia. Accessed Jan. 13, 2016.
  10. Negrin RS, et al. Overview of the treatment of chronic myeloid leukemia. Accessed Jan. 13, 2016.